Dive deep into the world of RET+ NSCLC treatment options with Dr. Maya Khalil, an esteemed Hematology-Oncologist from the Kirklin Clinic of UAB Hospital and an Assistant Professor of Medicine at the University of Alabama at Birmingham. As part of the 2022 Targeted Therapies Forum, Dr. Khalil offers her unparalleled expertise in managing RET Mutated NSCLC, shedding light on the most effective treatments for patients diagnosed with RET+ NSCLC.
A heartfelt thank you to our distinguished sponsors: #Novartis, #Janssen, #Blueprintmedicine, #TakedaOncology, #Astrazeneca, #LillyOncology, and #genentech for their unwavering support.
Yearning for more? Unlock a treasure trove of insights and groundbreaking research in oncology. Visit http://cancerGRACE.org/. Engage and interact with a global community of experts and advocates at https://cancergrace.org/forum.